ABOUT THE AHPPI

"An informal cross industry discussion group whose function is to address issues facing those involved in human pharmacology and to educate members through directed symposia at each of its 2 meetings per year."

The AHPPI is an informal cross-industry discussion group whose function is to address issues facing those involved in early phase drug development and to educate members through directed symposia at each of its 2 meetings per year.

The AHPPI constitution, which was updated at the September 2007 meeting, is attached on the right of this page. Members voted to increase the size of the committee by 1.

The Association has been in existence for over nearly 2 decades and has forged links with both other scientific societies with similar interests and with professional bodies such as the ABPI and ICR.   For several years, the association has been organizing joint biannual meetings with the clinical section of the British Pharmacological Society , all of which have been very successful and will continue in the future.

The AHPPI currently has 200 members. Membership of the group is open to persons in ethical pharmaceutical companies, contract organisations or others directly involved in early phase drug development of NCE's or NBE's . The Association has representation both in the membership and at committee level from both Industry and Contract Research Organisations.

email us! info@ahppi.org.uk